Zhaoyang Zeng Selected Research

Biomarkers (Surrogate Marker)

1/2022	A fluorescence strategy for circRNA quantification in tumor cells based on T7 nuclease-assisted cycling enzymatic amplification.
1/2022	Splicing factor derived circular RNA circCAMSAP1 accelerates nasopharyngeal carcinoma tumorigenesis via a SERPINH1/c-Myc positive feedback loop.
10/2020	EGFR-PKM2 signaling promotes the metastatic potential of nasopharyngeal carcinoma through induction of FOSL1 and ANTXR2.
9/2020	Upregulation of long non-coding RNA LOC284454 may serve as a new serum diagnostic biomarker for head and neck cancers.
2/2020	Correction to: Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapy.
1/2020	Emerging role of tumor-related functional peptides encoded by lncRNA and circRNA.
1/2020	Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapy.
4/2019	Upregulation and hypomethylation of lncRNA AFAP1‑AS1 predicts a poor prognosis and promotes the migration and invasion of cervical cancer.
1/2019	Expression and clinical significance of transcription factor 4 (TCF4) in epithelial ovarian cancer.
11/2018	Inhibin B suppresses anoikis resistance and migration through the transforming growth factor-β signaling pathway in nasopharyngeal carcinoma.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhaoyang Zeng Research Topics

Disease

105	Neoplasms (Cancer) 11/2022 - 09/2008
41	Nasopharyngeal Carcinoma 11/2022 - 05/2006
30	Neoplasm Metastasis (Metastasis) 11/2022 - 07/2011
21	Carcinogenesis 01/2022 - 09/2008
8	Inflammation (Inflammations) 12/2020 - 11/2008
7	Breast Neoplasms (Breast Cancer) 01/2022 - 07/2011
5	Epstein-Barr Virus Infections 01/2022 - 06/2015
4	Head and Neck Neoplasms (Head and Neck Cancer) 09/2021 - 09/2020
4	Ovarian Neoplasms (Ovarian Cancer) 05/2021 - 08/2019
4	Ovarian Epithelial Carcinoma 05/2020 - 01/2019
4	Dysbiosis 12/2018 - 09/2015
3	Urinary Bladder Neoplasms (Bladder Cancer) 11/2021 - 01/2020
3	Lung Neoplasms (Lung Cancer) 11/2021 - 01/2016
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2020 - 01/2017
3	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 12/2020 - 11/2014
3	Plasmacytoma 11/2019 - 01/2018
3	Lymphatic Metastasis 01/2019 - 10/2013
2	Disease Progression 01/2022 - 01/2019
2	Infections 05/2021 - 01/2019
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021 - 04/2019
2	Stomach Neoplasms (Stomach Cancer) 12/2020 - 11/2015
2	Adenocarcinoma of Lung 11/2020 - 01/2019
2	Hypoxia (Hypoxemia) 09/2020 - 01/2019
2	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 07/2011
2	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 12/2018 - 09/2015
2	Colonic Neoplasms (Colon Cancer) 01/2018 - 01/2018
2	Glioma (Gliomas) 07/2011 - 08/2006
1	Metabolic Diseases (Metabolic Disease) 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022

Drug/Important Bio-Agent (IBA)

35	Proteins (Proteins, Gene)FDA Link 11/2022 - 05/2006
30	Long Noncoding RNAIBA 01/2022 - 01/2014
23	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2012
18	MicroRNAs (MicroRNA)IBA 10/2021 - 07/2011
16	Messenger RNA (mRNA)IBA 11/2022 - 09/2008
14	Circular RNAIBA 11/2022 - 01/2017
12	RNA (Ribonucleic Acid)IBA 01/2022 - 02/2015
9	Biological ProductsIBA 11/2022 - 01/2018
6	ParaffinIBA 01/2021 - 02/2017
6	Complementary DNA (cDNA)IBA 08/2015 - 02/2007
4	3' Untranslated Regions (3' UTR)IBA 01/2022 - 01/2018
4	AntigensIBA 11/2021 - 10/2017
4	Pharmaceutical PreparationsIBA 01/2021 - 01/2013
4	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2019 - 09/2016
3	Untranslated RNA (Noncoding RNA)IBA 06/2022 - 10/2013
3	Peptides (Polypeptides)IBA 11/2021 - 01/2019
3	VaccinesIBA 11/2021 - 01/2019
3	Cancer VaccinesIBA 11/2021 - 01/2019
3	Glucose (Dextrose)FDA LinkGeneric 06/2021 - 01/2017
3	CytokinesIBA 05/2021 - 06/2015
3	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2018
3	Paclitaxel (Taxol)FDA LinkGeneric 03/2019 - 01/2015
3	LipidsIBA 01/2019 - 09/2015
3	Small Interfering RNA (siRNA)IBA 01/2018 - 01/2013
3	LactoferrinIBA 02/2015 - 11/2008
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2022 - 01/2021
2	Competitive Endogenous RNAIBA 01/2022 - 10/2018
2	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2022 - 10/2018
2	Phosphotransferases (Kinase)IBA 01/2022 - 01/2013
2	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 05/2021
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2021 - 07/2011
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2021 - 01/2020
2	triptolideIBA 09/2021 - 06/2021
2	HexokinaseIBA 09/2021 - 06/2021
2	GossypolIBA 08/2021 - 01/2020
2	Caspase 3 (Caspase-3)IBA 06/2021 - 02/2018
2	Small Cytoplasmic RNAIBA 05/2021 - 03/2021
2	6-methyladenineIBA 04/2021 - 01/2020
2	Chimeric Antigen ReceptorsIBA 01/2021 - 01/2018
2	Antisense RNA (Anti-Sense RNA)IBA 01/2021 - 10/2018
2	ErbB Receptors (EGF Receptor)IBA 10/2020 - 01/2018
2	CateninsIBA 05/2020 - 01/2018
2	Phenobarbital (Luminal)FDA Link 01/2020 - 01/2015
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 11/2019 - 11/2014
2	RNA IIBA 04/2019 - 01/2016
2	ProhibitinsIBA 01/2019 - 01/2013
2	LigandsIBA 01/2019 - 12/2007
2	carbendazimIBA 12/2018 - 09/2015
2	Triglycerides (Triacylglycerol)IBA 12/2018 - 09/2015
2	Mitogen-Activated Protein KinasesIBA 02/2018 - 11/2008
2	VimentinIBA 01/2018 - 06/2014
2	Interleukin-6 (Interleukin 6)IBA 09/2015 - 06/2015
2	Epstein-Barr virus encoded RNA 1IBA 10/2013 - 05/2009
2	Cyclin D1IBA 01/2013 - 05/2009
1	IronIBA 06/2022
1	IonsIBA 06/2022
1	Hydroxyl RadicalIBA 06/2022
1	phosphatidylinositol 3-phosphateIBA 01/2022
1	RNA Splicing FactorsIBA 01/2022
1	Autophagy-Related Protein-1 HomologIBA 01/2022
1	Beclin-1IBA 01/2022
1	UbiquitinIBA 01/2022
1	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 01/2022
1	TensinsIBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022

Therapy/Procedure

19	Therapeutics 01/2022 - 01/2013
10	Immunotherapy 01/2022 - 01/2018
3	Drug Therapy (Chemotherapy) 10/2021 - 01/2021
2	Radiotherapy 05/2021 - 04/2018
2	Precision Medicine 01/2021 - 09/2020
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2020 - 01/2019